ID: ALA162192

Max Phase: Preclinical

Molecular Formula: C12H13N3O2

Molecular Weight: 231.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(Nc2nc(O)nc(O)c2C)cc1

Standard InChI:  InChI=1S/C12H13N3O2/c1-7-3-5-9(6-4-7)13-10-8(2)11(16)15-12(17)14-10/h3-6H,1-2H3,(H3,13,14,15,16,17)

Standard InChI Key:  NIBSLWFIKYJSGX-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 231.25Molecular Weight (Monoisotopic): 231.1008AlogP: 2.25#Rotatable Bonds: 2
Polar Surface Area: 78.27Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.67CX Basic pKa: 0.59CX LogP: 3.78CX LogD: 3.78
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.74Np Likeness Score: -1.02

References

1. Trantolo DJ, Wright GE, Brown NC..  (1986)  Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines.,  29  (5): [PMID:3084785] [10.1021/jm00155a016]

Source